(Biosimilars are like generic drugs ... are made for biologic drugs.) The insulin glargine and lixisenatide combination is only available as the brand-name drug Soliqua 100/33.

Prices for insulin, the essential drug for treating diabetes, have plummetted to their lowest levels in a decade following a rise in generic options. Insulin prices averaged 19 cents per unit as ...

Basaglar is a long-acting insulin that may be available through ... This refers to a list of both brand-name and generic drugs a plan will cover. As such, it is important to check whether a ...

In addition, generic and branded competitors entering the insulin market face significant challenges, including up-front costs for clinical trials and manufacturing as well as relatively low ...

The popularity of the adjustable pliers spawned knockoffs until “Channellock” became a generic term, similar to Kleenex and Chapstick. To protect the brand, Champion-DeArment changed its name ...

Most Americans would prefer brand-name drugs—but end up buying generic versions because of the cost, new consumer research ...

that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions of its drug — Semglee cost $269 and a generic ...

Generic drugs contain the same active ingredients as their equivalent original branded drugs.

(Thyroid) California Gov. Gavin Newsom's (D) plan to produce cheap, generic insulin is far behind schedule, industry experts said. (CalMatters) In related news, a federal law that made companies ...

Revenue: INR1,146 crores in Q3, a growth of 4% year-on-year. Branded Generic Sales: INR834 crores in Q3, a growth of 10%. International Business - Asia: INR316 crores in Q3, a growth of 8%.